Date: 2014-09-16
Type of information: R&D agreement
Compound: ultra-high precision Intensity Modulated Proton Therapy, Dynamic Collimation System
Company: University of Iowa (USA - IA) IBA (Belgium)
Therapeutic area:
Type agreement:
Action mechanism:
Disease:
Details: * On September 16th, 2014, IBA (Ion Beam Applications SA) and University of Iowa have signed a research collaboration agreement and a technology license agreement to develop ultra-high precision Intensity Modulated Proton Therapy (IMPT). This agreement includes an exclusive license on the Dynamic Collimation System (DCS) recently developed and presented by the University of Iowa at the American Association of Physicists in Medicine (AAPM) meeting in Austin, Texas. The Dynamic Collimation System is an innovative device developed by University of Iowa Carver College of Medicine faculty members to improve dose conformity in IMPT. The applications for the DCS could extend to many tumor sites and is expected to improve hypo-fractionated treatments in Proton Therapy on a five-year horizon.http://www.ncbi.nlm.nih.gov/pubmed/25186376
Financial terms:
Latest news:
